Lung Cancer News

Lung disease that patients with cancer experience from the antibody-drug conjugate fam-trastuzumab deruxtecan-nxki can be treated effectively if detected early and managed promptly, according to study results published in ESMO Open.

The FDA granted fast track designation to sapanisertib for treatment of certain patients with non-small cell lung cancer.

A collaboration of researchers has developed a testing method for methylome sequencing of cell-free DNA that accurately detects and locates certain types of early-stage cancer, study results published in Nature Communications showed.

The FDA granted orphan drug designation to SynKIR-110, an investigational chimeric antigen receptor T-cell therapy, for treatment of mesothelin-expressing mesothelioma.

The FDA approved bevacizumab-adcd for treatment of six cancer types, according to a press release from the biosimilar’s manufacturer.

Anxiety and depression that may follow a cancer diagnosis, especially as a patient approaches the end of life, can be incapacitating and difficult to assuage.

This year’s European Society for Medical Oncology Congress featured potentially practice-changing research in kidney cancer, cutaneous squamous cell carcinoma, lung cancer and melanoma.

The FDA Oncologic Drugs Advisory Committee on Thursday voted against questions regarding the benefits vs. risks of two cancer treatments for which new drug applications have been filed.

The FDA granted regular approval to selpercatinib for treatment of certain patients with non-small cell lung cancer.

In its 12th annual Cancer Progress Report, American Association for Cancer Research outlined substantial strides against cancer, including a 2.3% decrease in cancer deaths between 2016 and 2019.